Brief: Huakang Biomedical Holdings Co Sees Qtrly Loss Attributable Of About Rmb2.8 Mln

Joyzyme

04/05/2020 09:56

May 4 (Reuters) - Huakang Biomedical Holdings Co Ltd
 8622.HK :
    * SEES SIGNIFICANT INCREASE IN QTRLY LOSS ATTRIBUTABLE FROM
ABOUT
RMB148,000 TO ABOUT RMB2.8 MILLION
    * EXPECTED RESULT DUE TO SIGNIFICANT DECLINE IN SALES
REVENUE IN
MARKETS IN CHINA DUE TO COVID-19 EPIDEMIC

Source text for Eikon:  ID:nHKS4J9pXK 
Further company coverage:  8622.HK 

 ((Reuters.Briefs@thomsonreuters.com;))